Down-regulation of CCL17 in cancer-associated fibroblasts inhibits cell migration and invasion of breast cancer through ERK1/2 pathway

Explore this paper's citation graph

Summary

CCL17 may function as a novel biomarker as well as potential therapeutic target against BC and CAF-secreted CCL17 promotes BC cell migration and invasion through the DUSP6-dependent ERK1/2 pathway.

Type
article
Published
2019-08-07
Cited by
13
References
38
Access
Open access

Keywords

Cancer-Associated Fibroblasts, Cancer, Breast cancer, Cancer research, Cell migration

References

Cited by

Related papers